IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples